AniCell products originate from equine amniotic tissue collected following healthy births. The tissue provides a naturally organized extracellular matrix containing structural proteins and other matrix-associated components—providing veterinarians with a biological, tissue-derived scaffold rather than a synthetic material.

Amniotic membrane is recognized in scientific literature for its naturally organized extracellular matrix and relatively low immunogenic characteristics. These properties have made it an important material in biological scaffold research.

AniCell utilizes equine amniotic tissue to provide naturally derived scaffold materials for veterinarian-directed applications.

By eliminating the need for patient-specific tissue collection, culture, or on-site concentration, AniCell provides a streamlined approach to incorporating regenerative tissue-based technology into veterinary practice

One advantage of AniCell’s amnion-derived technology is its versatility at the point of care. Products can be maintained in veterinary inventory and are available for use when the veterinarian determines they are appropriate. Implantable formats provide an amnion-derived tissue scaffold, while topical membrane products provide a flexible, conformable biological covering. Multiple product formats allow veterinarians to incorporate amniotic tissue into individualized, multimodal management plans based on the patient and clinical circumstances.